DaVita Inc. (DVA): Price and Financial Metrics
DaVita Inc. (DVA)
Today's Latest Price: $117.48 USD
Updated Jan 27 3:42pm
Add DVA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
DVA Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for DVA is 7.33 -- better than 95.51% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 9.12 for Davita Inc; that's greater than it is for 89.72% of US stocks.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for DVA comes in at 12.7% -- higher than that of 85.89% of stocks in our set.
- Stocks that are quantitatively similar to DVA, based on their financial statements, market capitalization, and price volatility, are LAMR, CE, IRM, NUE, and NRG.
- Visit DVA's SEC page to see the company's official filings. To visit the company's web site, go to www.davita.com.
DVA Stock Price Chart Interactive Chart >
DVA Price/Volume Stats
| Current price | $117.48 | 52-week high | $125.28 |
| Prev. close | $119.26 | 52-week low | $62.20 |
| Day low | $116.90 | Volume | 405,836 |
| Day high | $118.96 | Avg. volume | 585,642 |
| 50-day MA | $114.47 | Dividend yield | N/A |
| 200-day MA | $91.84 | Market Cap | 13.16B |
DaVita Inc. (DVA) Company Bio
DaVita Healthcare Partners delivers dialysis services to patients with chronic kidney failure and end stage renal disease. The company was founded in 1994 and is based in Denver, Colorado.
DVA Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $117.48 | $204.32 | 71% |
We started the process of determining a valid price forecast for Davita Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Davita Inc ranked in the 64th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 72.17%. In terms of the factors that were most noteworthy in this DCF analysis for DVA, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 57. Its equity weight surpasses that of merely 13.34% of free cash flow generating stocks in the Healthcare sector.
- Davita Inc's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 2.56% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 68% |
| 1% | 70% |
| 2% | 71% |
| 3% | 73% |
| 4% | 75% |
| 5% | 76% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as DVA, try ANTM, DGX, NVO, MCK, and FMS.
Loading social stream, please wait...